Vertex Pharmaceuticals Inc. buy The Goldman Sachs Group, Inc.
Start price
07.05.25
/
50%
€382.55
Target price
07.05.26
-
Performance (%)
-5.59%
End price
08.05.26
€361.15
Summary
This prediction ended on 08.05.26 with a price of €361.15. With a performance of -5.59%, the BUY prediction by The_Goldman_Sachs_Gr finished with a loss. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | 3.638% | 3.638% | 40.954% |
| iShares Core DAX® | -1.059% | 5.007% | 6.596% |
| iShares Nasdaq 100 | -2.387% | 0.864% | 25.791% |
| iShares Nikkei 225® | -4.361% | 1.211% | 41.309% |
| iShares S&P 500 | -1.778% | 1.391% | 21.037% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Trading Vertex Pharmaceuticals Inc.
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its "buy" rating re-affirmed by analysts at The Goldman Sachs Group, Inc..
Ratings data for VRTX provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€397.35
31.01.24
31.01.24
€515.17
31.01.25
31.01.25
11.04%
01.02.25
01.02.25
